Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors
- DOI
- 10.1016/j.ctarc.2025.101087
- Published
- 2026
- Container
- Cancer Treatment and Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2025.101087,
title = {Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors},
author = {Hiroki Ito and Masayuki Shirasawa and Yuki Akazawa and Akinori Watanabe and Tomohiro Furo and Ayumi Nishimura and Junpei Endo and Atsuko Watanabe and Hiroto Kurata and Maito Nakano and Seiichiro Kusuhara and Mikiko Kakegawa and Yoshiro Nakahara and Takashi Sato and Jiichiro Sasaki and Toshitaka Maeno and Katsuhiko Naoki},
year = {2026},
journal = {Cancer Treatment and Research Communications},
doi = {10.1016/j.ctarc.2025.101087},
url = {https://doi.org/10.1016/j.ctarc.2025.101087}
}RIS
TY - JOUR TI - Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors AU - Hiroki Ito AU - Masayuki Shirasawa AU - Yuki Akazawa AU - Akinori Watanabe AU - Tomohiro Furo AU - Ayumi Nishimura AU - Junpei Endo AU - Atsuko Watanabe AU - Hiroto Kurata AU - Maito Nakano AU - Seiichiro Kusuhara AU - Mikiko Kakegawa AU - Yoshiro Nakahara AU - Takashi Sato AU - Jiichiro Sasaki AU - Toshitaka Maeno AU - Katsuhiko Naoki PY - 2026 JO - Cancer Treatment and Research Communications DO - 10.1016/j.ctarc.2025.101087 UR - https://doi.org/10.1016/j.ctarc.2025.101087 ER -
APA
Ito, H., Shirasawa, M., Akazawa, Y., Watanabe, A., Furo, T., Nishimura, A., Endo, J., Watanabe, A., Kurata, H., Nakano, M., Kusuhara, S., Kakegawa, M., Nakahara, Y., Sato, T., Sasaki, J., Maeno, T., & Naoki, K. (2026). Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101087
Source records
- crossref · retrieved 2026-09-27T00:19:22.403Z